Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|August 1, 2008
Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, TurkeyAynur Gulcan, Erim Gulcan, Aysun Toker, et al.
Allergologia Et Immunopathologia|July 11, 2026
Is local anaesthetic drug allergy really common? A 10-year single-centre retrospective analysisNihal Yıldırım, Mustafa Asım Demirkol, Zeynep Yegin Katran, et al.
The Tohoku Journal of Experimental Medicine|November 25, 2003
Epiglottic tuberculosis in a patient treated with steroids for Addison's diseaseErol Egeli, Fatih Oghan, Murat Alper, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 7, 2017
Pregnancy-associated plasma protein-A (PAPP-A) levels in patients with severe allergic asthma are reduced by omalizumabIsmet Bulut, Zeynep F Ozseker, Abdurrahman Coskun, et al.
Allergologia Et Immunopathologia|September 9, 2025
Antituberculosis drug-induced hypersensitivity: clinical characteristics and risk factorsZeynep Yegin Katran, İsmet Bulut, Aylin Babalık, et al.
Lung Cancer (Amsterdam, Netherlands)|February 28, 2009
Analysis of HLA class I and II alleles regarding to lymph node and distant metastasis in patients with non-small cell lung cancerIsmet Bulut, Mehmet Meral, Hasan Kaynar, et al.
International Journal of Clinical and Experimental Medicine|November 25, 2014
MDR-1 gene C/T polymorphism in COPD: data from Aegean part of TurkeyUmran Toru, Ceylan Ayada, Osman Genç, et al.
Postepy Dermatologii I Alergologii|September 18, 2024
Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization schemeİsmet Bulut, Zeynep Yegin Katran, Aylin Babalık, et al.
Northern Clinics of Istanbul|January 23, 2026
Severe cutaneous adverse drug reactions due to antituberculosis drugs and their managementMetin Keren, Aysun Aynaci, Ismet Bulut, et al.
Tumori|April 26, 2007
Effect of symptom-to-treatment interval on prognosis in lung cancerAll Nihat Annakkaya, Peri Arbak, Oner Balbay, et al.
Pageof 6